STUDY QUESTION Is it safe to perform controlled ovarian stimulation (COS) for fertility
preservation before starting anticancer therapies or ART after treatments in young breast …

Background Even small delays in the treatment of breast cancer are a frequently expressed
concern of patients. Knowledge about this subject is important for clinicians to counsel …

In 2018, the predicted number of new breast cancers in 28 European Union (EU) countries
was 404 920, with estimated age-adjusted annual incidence of breast cancer of 144.9/100 …

In 2012, the estimated age-adjusted annual incidence of breast cancer in 40 European
countries was 94.2/100 000 and the mortality 23.1/100 000 [1]. The incidence increased …

Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆
- Annals of Oncology Skip to Main Content Advertisement Annals of Oncology European …

Importance Adjuvant chemotherapy improves outcomes of patients with breast cancer.
However, the optimal timing of chemotherapy initiation is unknown. Delayed administration …

Recent reports have highlighted the distinct roles and occasional tension between
randomised controlled trials (RCTs) and population-based observational research (Concato …

In 2008, the estimated age-adjusted annual incidence of breast cancer in Europe (40
countries) was 88.4/100 000 and the mortality 24.3/100 000. The incidence increased after …

Precision oncology has made significant advances, mainly by targeting actionable mutations
in cancer driver genes. Aiming to expand treatment opportunities, recent studies have begun …

Purpose For patients with breast cancer (BC), the optimal time to initiation of adjuvant
chemotherapy (TTC) after definitive surgery is unknown. We evaluated the association …